Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function

Katrina Go Yamazaki, Aleksander Y. Andreyev, Pilar Ortiz-Vilchis, Susanna Petrosyan, Ajit S. Divakaruni, Sandra E. Wiley, Christine De La Fuente, Guy Perkins, Guillermo Ceballos, Francisco Villarreal, Anne N. Murphy

Producción científica: Contribución a una revistaArtículorevisión exhaustiva

44 Citas (Scopus)

Resumen

Background Targeting the mitochondria during ischemia/reperfusion (IR) can confer cardioprotection leading to improved clinical outcomes. The cardioprotective potential of (-)-epicatechin (EPI) during IR via modulation of mitochondrial function was evaluated. Methods and results Ischemia was induced in rats via a 45 min occlusion of the left anterior descending coronary artery followed by 1 h, 48 h, or 3 week reperfusion. EPI (10 mg/kg) was administered IV 15 min prior to reperfusion for the single dose group and again 12 h later for the double dose group. Controls received water. Experiments also utilized cultured neonatal rat ventricular myocytes (NRVM) and myoblasts. A single dose of EPI reduced infarct size by 27% at 48 h and 28% at 3 week. Double dose treatment further decreased infarct size by 80% at 48 h, and 52% by 3 weeks. The protective effect of EPI on mitochondrial function was evident after 1 h of reperfusion when mitochondria demonstrated less respiratory inhibition, lower mitochondrial Ca2 + load, and a preserved pool of NADH that correlated with higher tissue ATP levels. Mechanistic studies in NRVM revealed that EPI acutely stimulated maximal rates of respiration, an effect that was blocked by inhibitors of the mitochondrial pyruvate carrier, nitric oxide synthase, or soluble guanylyl cyclase. In myoblasts, knockdown of components of the mitochondrial pyruvate carrier blocked EPI-induced respiratory stimulation. Conclusions IV EPI confers cardioprotection via preservation of mitochondrial function potentially through enhanced substrate provision. These provocative results document a novel mechanism of a natural product with potential clinical utility.

Idioma originalInglés
Páginas (desde-hasta)297-306
Número de páginas10
PublicaciónInternational Journal of Cardiology
Volumen175
N.º2
DOI
EstadoPublicada - 1 ago. 2014

Huella

Profundice en los temas de investigación de 'Intravenous (-)-epicatechin reduces myocardial ischemic injury by protecting mitochondrial function'. En conjunto forman una huella única.

Citar esto